Moreover, because aberrant methylation of COX-2 is frequent in colon cancer [13], it will be very important to investigate whether transient cyclical methylation occurring during transcription cycles may become inaccurate and distorted thus potentially contributing to aberrant methylation changes at COX-2 gene promoter during neoplastic progression. The gene discussed is PTGS2; the disease is colonic neoplasm.